Absence of LP activity in MASP-2 gene-targeted mice and in WT mice treated with MASP-2 inhibitors confers significant protection from ischemia/reperfusion injury in mouse models of myocardial, intestinal and cerebral ischemia (20, 29, 37). The gene discussed is MASP2; the disease is Cerebral ischemia.